7ZRT
Crystal structure of human Urokinase-type plasminogen activator in complex with bicycle peptide inhibitor UK970
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | ESRF BEAMLINE ID23-2 |
Synchrotron site | ESRF |
Beamline | ID23-2 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2021-07-01 |
Detector | DECTRIS PILATUS3 X 2M |
Wavelength(s) | 0.87313 |
Spacegroup name | H 3 |
Unit cell lengths | 121.315, 121.315, 42.817 |
Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
Resolution | 39.680 - 1.800 |
R-factor | 0.209 |
Rwork | 0.208 |
R-free | 0.22900 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 3qn7 |
RMSD bond length | 0.011 |
RMSD bond angle | 1.655 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | MOLREP |
Refinement software | REFMAC (5.8.0267) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 39.680 | 1.840 |
High resolution limit [Å] | 1.800 | 1.800 |
Rmerge | 0.140 | 0.820 |
Number of reflections | 21768 | 21768 |
<I/σ(I)> | 15.4 | |
Completeness [%] | 99.9 | |
Redundancy | 7.9 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 4.3 | 293 | 7% PEG400, 50mM Citrato, 1.8 M (NH4)2SO4; 20% Ethylene glycol |